Ireland should oppose EU proposals on regulatory protection for medicines
European Commission has proposed reducing the period of regulatory data protection from eight years to six years
Irish Pharmaceutical Healthcare Association (Ipha)
Collaborating through gritted teeth
Pharma sector stakeholders still scoring points off each other despite new resources and talk of ‘shared purpose’
Public cancer patients being offered treatment that is second best to one in private system, conference hears
Minister for Health tells medicines industry conference he has sanctioned 34 new hires to speed up vetting process for new treatments
Patients waiting over two years for access to EU- approved medicines
Irish approvals process delays mean public patients forced to wait for new therapies already available to private patients
Ozempic drug-maker pushed Government to oppose EU pharma reforms
Proposals would lower time period a company has protection over research behind drugs they develop
Pharmacists dispensing unlicensed medication due to shortage, union says
One source working in the pharmaceutical industry warned about the use of EMPs, stating there were two recalls in the sector in recent months for potential harm to patients
Demand for weight loss drug more than 45 times higher than expected
New obesity medicines have potential to use up entire State drugs budget, conference hears
Mental health services must be prised from grip of psychiatry
Mac MacLachlan: Our mental health services have not evolved to reflect what we know about mental health
Obesity drug firm paid health staff €345,000 over three years
Novo Nordisk’s UK affiliate has been suspended from industry body there for marketing breaches
John Burns: What the State paid Bobby Kerr, Michael Portillo and Mary Kennedy
Any Other Business: Apple’s Irish activities, Irish Mortgage Holders Organisation scales back, greener fuel and the odds on David McRedmond being RTE’s next DG
Heartbreak of children lost to rare disease for which there was no cure
Even on a pure financial basis, families insist that expensive breakthrough treatments are better value for the State than caring for terminally ill children
New medicines must be affordable to all, Minister tells drug companies
Stephen Donnelly tells pharma conference government and industry need to work closer together to improve patient access
Big pharma companies warn against loosening rules on intellectual property
New EU strategy due this month will focus on improving affordability of and access to medicines across member states
Hope on the horizon for families of thousands of Alzheimer’s patients
Giving doctors access to breakthrough medicines is priority for Biogen boss Michael O’Connell in his role as Irish Pharmaceutical Healthcare Association president
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices